Publication | Open Access

Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer

MedicinePharmacologyColorectal CancerSphingosine-1-phosphate Receptor 2PharmacotherapyBiological EvaluationAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer ResearchDrug Discovery